Argus Downgrades Emerson (EMR) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts EMR Hot Sheet
Price: $170.87 +2.69%
Rating Summary:
27 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
27 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Argus downgraded Emerson (NYSE: EMR) from Buy to Hold.
For more ratings news on Emerson click here and for the rating history of Emerson click here.
Shares of Emerson closed at $46.88 yesterday.
For more ratings news on Emerson click here and for the rating history of Emerson click here.
Shares of Emerson closed at $46.88 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Argus Downgrades Xylem (XYL) to Hold
- Harmony Biosciences posts Q3 revenue of $269M, reaffirms 2026 outlook
- Sunshine Silver added to Solactive Global Silver Miners Index
Create E-mail Alert Related Categories
DowngradesRelated Entities
ArgusSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
